Integer Holdings Corporation (ITGR) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
As of 2026-11-03, Integer Holdings Corporation (NYSE: ITGR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $126.59 (+0.06% 1D, market cap $4.30B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, ITGR ranks #106 in composite RQD confidence.
Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ITGR carries a Roarable C+ (67/100 RQD), trailing P/E of 41.8x, gross margin of 27.0%, and ROIC of 6.0%. By comparison, LIVN (LivaNova PLC) holds a C+ grade (66/100 RQD, P/E N/A, ROIC 17.3%, cap $4.35B) and AXGN (Axogen Inc.) posts a D+ grade (53/100 RQD, P/E N/A, ROIC -2.6%, cap $2.95B). Among the 5-stock peer group, TMDX leads on earnings multiple (12.2x) while TMDX leads on capital efficiency (18.1% ROIC).
Per ITGR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001114483), Integer Holdings Corporation generated $1.85B in revenue (+8.0% YoY), $102.8M in net income, and $105.1M in free cash flow against $3.41B in total assets and $1.19B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 42x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±1.8% realized swing band)
SEC XBRL FY 2025 (10-K): 5.7% FCF Margin ($105.1M FCF) & 27% Gross Margin
Cannibal Buyback (-0.96% YoY Shares) & executive Form 4 sales trim 9 pts from alignment
Even with a 67/100 (C+) score, ITGR faces multiple-compression risk if 41.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Priced at 42x earnings—high expectations leave less room for a lukewarm quarter.
Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 24.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($126.28) or 200D SMA ($101.43) invalidates the momentum regime and cuts Target Base ($131.72) toward Bear Floor ($102.74).
Integer Holdings Corporation (ITGR) advanced +0.06% to $126.59, trading at 99% of its 52-week range ($66 – $126.83). Solid 27% profit margin (6% return on capital), mixed timing at 42x P/E—hold if owned, no rush to chase.
Integer Holdings barely moved in regular trading, with the stock edging up 0.06% to close at $126.59, yet the fresh Q3 2026 numbers tell a much tighter story beneath that calm surface. Net income from ongoing operations
Medical technology company Integer Holdings (NYSE:ITGR) fell short of the market’s revenue expectations in Q3 2026, with revenue falling 3.9% year on year to $449.7 million. Its non-GAAP profit of $1.34 per share was 20.
Integer (ITGR) delivered earnings and revenue surprises of -18.79% and -1.67%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
PLANO, Texas (AP) — PLANO, Texas (AP) — Integer Holdings Corp. (ITGR) on Thursday reported third-quarter earnings of $15 million.
Integer Holdings (NYSE:ITGR) reported quarterly earnings of $1.34 per share which missed the analyst consensus estimate of $1.69 by 20.71 percent. This is a 25.14 percent decrease over earnings of $1.79 per share from
Integer Holdings has delivered a sharp rerating over the past year, and its share price now aligns with an agreed buyout proposal from KKR that values the business at several billion dollars. With the stock trading near
PLANO, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”) and Armstrong Parent, Inc. (“Parent”) today announced that, in connection with Parent’s proposed acqu
NEW CANAAN, Conn., Oct. 21, 2026 (GLOBE NEWSWIRE) -- In the third quarter of 2026, private equity firms and their sponsored companies (“PE Buyers,” collectively) announced 135 transactions in the healthcare M&A market, o
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +8.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ITGR today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ITGR. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, Integer Holdings Corporation (ITGR) ranks #106 by composite RQD confidence (67/100, grade C+) and #172 by equity capitalization ($4.30B). Within this direct 5-issuer industry benchmark cohort, TMDX leads on earnings valuation at 12.2x trailing P/E, while TMDX leads on capital efficiency and profitability with 18.1% ROIC and 59.9% gross margin. ITGR currently leads its immediate peer cohort in composite quantitative strength at 67/100 (C+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ITGR
ACTIVE
Integer Holdings Corporation | C+ | 67/100 | 41.8x | 27.0% | 6.0% | +0.06% | $4.30B | Benchmark Subject |
| LIVN LivaNova PLC | C+ | 66/100 | — | 67.7% | 17.3% | -2.81% | $4.35B | /livn-vs-itgr → |
| AXGN Axogen Inc. | D+ | 53/100 | — | 74.3% | -2.6% | -0.52% | $2.95B | /axgn-vs-itgr → |
| TMDX TransMedics Group Inc. | C- | 61/100 | 12.2x | 59.9% | 18.1% | -1.68% | $2.29B | /tmdx-vs-itgr → |
| CNMD CONMED Corporation | C | 62/100 | 28.9x | 54.6% | 7.8% | -3.13% | $1.32B | /cnmd-vs-itgr → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Integer Holdings Corporation (ITGR) reported GAAP revenue of $1.85B (+8.0% vs. FY2024 revenue of $1.72B , and +19.2% cumulative change since FY2023) , GAAP net income of $102.8M, operating cash flow of $196.1M, and free cash flow of $105.1M (+5.3% YoY). On the balance sheet, ITGR closed FY2025 with $3.41B in total assets against $1.19B in total debt (Altman Z-Score: 2.91, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.85B | $102.8M | $196.1M | $105.1M | $3.41B | $1.19B |
| FY2024 (FY) | 2024-12-31 | $1.72B | $119.9M | $205.2M | $99.8M | $3.08B | $980.2M |
| FY2023 (FY) | 2023-12-31 | $1.56B | $90.7M | $180.2M | $110.2M | $2.37B | $553.5M |
As of 2026-11-03, Integer Holdings Corporation (NYSE: ITGR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $126.59 (+0.06% 1D, market cap $4.30B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, ITGR ranks #106 in composite RQD confidence.
Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ITGR carries a Roarable C+ (67/100 RQD), trailing P/E of 41.8x, gross margin of 27.0%, and ROIC of 6.0%. By comparison, LIVN (LivaNova PLC) holds a C+ grade (66/100 RQD, P/E N/A, ROIC 17.3%, cap $4.35B) and AXGN (Axogen Inc.) posts a D+ grade (53/100 RQD, P/E N/A, ROIC -2.6%, cap $2.95B). Among the 5-stock peer group, TMDX leads on earnings multiple (12.2x) while TMDX leads on capital efficiency (18.1% ROIC).
Per ITGR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001114483), Integer Holdings Corporation generated $1.85B in revenue (+8.0% YoY), $102.8M in net income, and $105.1M in free cash flow against $3.41B in total assets and $1.19B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 42x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
ITGR last traded at $126.59 (+0.06% on volume of 571,724 shares), positioning the stock +0.25% above its 50-day simple moving average ($126.28) and +24.81% above its 200-day simple moving average ($101.43). Across its 52-week range of $66.00 to $126.83, ITGR sits at the 99.6% percentile with a 14-day RSI of 61.4 (BULLISH MOMENTUM) and an implied next-earnings move of ±1.8% ($124.31 to $128.87).
Why ITGR Stock advanced +0.06% Today — RQD Quant Desk Flash. Solid 27% profit margin (6% return on capital), mixed timing at 42x P/E—hold if owned, no rush to chase.
Per the Roarable RQD rating, ITGR scores 67 out of 100, a letter grade of C+, with the verdict "Roarable Hold — Upper Neutral / Watch for Breakout." The five pillars are: Fundamental Cash Engine at 14 of 20 (ROIC 6%; FCF yield 2.44%), Whale 13F Flow at 16 of 20 (institutional accumulation and options positioning), Insider Conviction at 11 of 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 13 of 20 (Beta 1.02; sector sensitivity), and Forensic Balance Sheet at 13 of 20 (Altman Z 2.91; Piotroski F 7/9; Debt/Equity 0.68).
For a prospective investor, the rating's strongest pillar is institutional positioning, which the RQD places at 16 of 20, while insider conviction is the weakest at 11 of 20. The cash-engine pillar is moderate: the RQD attributes 14 of 20 to it, consistent with the 6% ROIC and 2.44% FCF yield shown in the market data. The forensic pillar (13 of 20) reflects a Piotroski score of 7 of 9 and an Altman Z-Score of 2.91, alongside a Debt/Equity ratio of 0.68. Upside drivers implied by the scoring are institutional accumulation and balance sheet strength; valuation tradeoffs are visible in the elevated P/E (TTM) of 41.8 and forward P/E of 38.9 relative to a 2.44% FCF yield. The verdict's "Watch for Breakout" language signals the rating system views the stock as near neutral with potential for a directional move, not as a conclusive buy or sell. This is an analytical summary, not personalized financial advice.
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $1853.6M | $221.3M | $102.8M | N/A | $105.1M | $17.2M | $1185.2M |
| FY 2024 | $1716.6M | $208.2M | $119.9M | N/A | $99.8M | $46.5M | $980.2M |
| FY 2023 | $1555.7M | $163.3M | $90.7M | N/A | $110.2M | N/A | $553.5M |
Per the market data, gross margin is 27%, operating margin 11.9%, and net margin 5.5%, with ROIC at 6%. Per the RQD forensic pillar, the Altman Z-Score is 2.91 and the Piotroski F-Score is 7 of 9. The balance sheet shows debt rising from $553.5M (FY 2023) to $1185.2M (FY 2025) while cash fell from $46.5M (FY 2024) to $17.2M (FY 2025). Debt/Equity is 0.68 per the RQD forensic inputs.
Real-time company headlines, analyst actions, and sector developments for Integer Holdings Corporation (ITGR) • Click "Debate This Headline" to argue it in the Roar Pit below
Integer Holdings barely moved in regular trading, with the stock edging up 0.06% to close at $126.59, yet the fresh Q3 2026 numbers tell a much tighter story beneath that calm surface. Net income from ongoing operations
Medical technology company Integer Holdings (NYSE:ITGR) fell short of the market’s revenue expectations in Q3 2026, with revenue falling 3.9% year on year to $449.7 million. Its non-GAAP profit of $1.34 per share was 20.
Integer (ITGR) delivered earnings and revenue surprises of -18.79% and -1.67%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
PLANO, Texas (AP) — PLANO, Texas (AP) — Integer Holdings Corp. (ITGR) on Thursday reported third-quarter earnings of $15 million.
Integer Holdings (NYSE:ITGR) reported quarterly earnings of $1.34 per share which missed the analyst consensus estimate of $1.69 by 20.71 percent. This is a 25.14 percent decrease over earnings of $1.79 per share from
Integer Holdings has delivered a sharp rerating over the past year, and its share price now aligns with an agreed buyout proposal from KKR that values the business at several billion dollars. With the stock trading near
Welcome to the ITGR (Integer Holdings Corporation) Roar Pit. Current RQD Composite is 67/100 (Roarable Hold — Upper Neutral / Watch for Breakout) in Biotechnology: Electromedical & Electrotherapeutic Apparatus. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (41.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Everyone in here is repeating the bull case on ITGR, but look at what you are paying: 41.8x trailing P/E with 27.0% gross margins. Unless Integer Holdings Corporation expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
Looking at the 5-pillar RQD breakdown on ITGR, the market is fixating on short-term headline noise in Biotechnology: Electromedical & Electrotherapeutic Apparatus and ignoring the balance sheet and cash flow trajectory. At $126.52 (52-wk range $63.75 - $126.83), any beat on forward guidance forces shorts and underweight funds to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).